shortagewatch

Home / Cancer and immune system / Rituximab

ATC L01FA01 · Antineoplastic Agents

Rituximab shortage

As of 31 Oct 2026, Rituximab has a reported shortage in 2 of the 5 countries we track (Italy, Spain), covering 7 products.

Countries2/5
Products7packs or presentations
Short since2 Oct 202513 months ago
Earliest returnnot givencompany estimate
No return date7products
Main reasonIncreased demand
GermanyNo reported shortageItaly5 packs shortSpain2 packs shortAustriaNo reported shortageBelgiumNo reported shortage

Timeline

ItalySpain
2026RUXIENCERUXIENCERUXIENCERUXIENCETRUXIMATRUXIMARIXATHONRIXATHONRIXATHONRIXATHONITUXREDI 100 MG CONCENTRADO PARA SOLUCION PAITUXREDI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 2 viales de 10 mlITUXREDI 500 MG CONCENTRADO PARA SOLUCION PAITUXREDI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 50 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITRUXIENCEPFIZER EUROPE MA EEIG26 Nov 2025not givenIncreased demand
Elevata richiesta
ITRUXIENCEPFIZER EUROPE MA EEIG8 Jan 2026not givenIncreased demand
Elevata richiesta
ITTRUXIMACELLTRION HEALTHCARE HUNGARY KFT5 Jul 2026not givenIncreased demand
Elevata richiesta (carenza relativa solo al canale ospedaliero)
ITRIXATHONSANDOZ GMBH6 Aug 2026not givenIncreased demand
Elevata richiesta
ITRIXATHONSANDOZ GMBH1 Oct 2026not givenManufacturing problem
Problemi produttivi
ESITUXREDI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 2 viales de 10 mlReddy Holding Gmbh2 Oct 2025not givenNot stated
ESITUXREDI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 50 mlReddy Holding Gmbh2 Oct 2025not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.